Patients' tradeoffs in gene therapy decisions

While largely ineffective medications for the treatment of Alzheimer’s Disease have gotten a great deal of press, an “orphan” disease – sickle cell disease – is in a similar situation. It is a devastating disease, and there seems to be a gene treatment on the horizon, one that comes with risks and benefits. How do patients calculate what to do?